Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
75.47
+0.34 (0.45%)
Apr 25, 2025, 11:51 AM EDT - Market open

Edwards Lifesciences Market Cap

Edwards Lifesciences has a market cap or net worth of $44.21 billion as of April 25, 2025. Its market cap has decreased by -20.95% in one year.

Market Cap
44.21B
Enterprise Value
40.73B
1-Year Change
-20.95%
Ranking
Category
Stock Price
$75.47

Market Cap Chart

Since March 27, 2000, Edwards Lifesciences's market cap has increased from $958.50M to $44.21B, an increase of 4,512.10%. That is a compound annual growth rate of 16.50%.

History

DateMarket Cap% Change
Apr 24, 202544.17B1.16%
Dec 31, 202443.66B-5.51%
Dec 29, 202346.21B0.17%
Dec 30, 202246.13B-42.97%
Dec 31, 202180.88B42.25%
Dec 31, 202056.86B16.86%
Dec 31, 201948.66B51.96%
Dec 31, 201832.02B34.25%
Dec 29, 201723.85B19.05%
Dec 30, 201620.03B17.59%
Dec 31, 201517.04B25.03%
Dec 31, 201413.63B89.40%
Dec 31, 20137.19B-30.86%
Dec 31, 201210.41B29.03%
Dec 30, 20118.06B-12.62%
Dec 31, 20109.23B87.85%
Dec 31, 20094.91B60.64%
Dec 31, 20083.06B17.27%
Dec 31, 20072.61B-4.23%
Dec 29, 20062.72B10.05%
Dec 30, 20052.47B0.91%
Dec 31, 20042.45B37.56%
Dec 31, 20031.78B16.52%
Dec 31, 20021.53B-6.49%
Dec 31, 20011.64B57.15%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 772.03B
UnitedHealth Group 386.16B
Johnson & Johnson 372.77B
AbbVie 319.07B
Novo Nordisk 276.96B
Abbott Laboratories 224.39B
AstraZeneca 215.41B
Novartis AG 210.89B
Market Cap Rankings